EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FLASH Radiotherapy Enhances the Therapeutic Ratio in an Embryonic In Vivo Model of Pancreatic Carcinoma

Noemi Giannini, Alessandra Gonnelli, Giovanni Gadducci, Paola Puccini, Andrea Cavalieri, Luigi Masturzo, Jake Harold Pensavalle, Mariagrazia Celentano, Fabio Di Martino, Federico Di Cocco, Cristian Scatena, Antonio Giuseppe Naccarato und 7 weitere

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c19638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Noemi Giannini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanotechnology Innovation@NEST-Istituto Italiano di Tecnologia, Piazza San Silvestro 12, 56127 Pisa, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Universit? e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) is a commonly employed treatment in oncological setting. Unfortunately, the therapeutic dose required for tumor control often induces significant side effects in normal tissues, leading to suboptimal outcomes and reduced patient quality of life. FLASH radiotherapy (FLASH-RT) is distinguished by its exceptionally high dose rates, surpassing 40 Gy/s. This advancement has emerged as a promising innovation in the field of cancer treatment. Indeed, FLASH-RT may reduce normal tissue toxicity compared to conventional radiotherapy (CONV-RT) while maintaining tumor control. Here, FLASH-RT and CONV-RT have been compared in an alternative embryonic model of pancreatic carcinoma, a cancer type with poor prognosis and limited therapeutic options. The chorioallantoic membrane models (CAMs) have been employed to assess the tumor control and the treatment toxicity by analyzing the embryo survival. FLASH-RT exhibited significantly reduced off-target toxicity on the embryos, as evidenced by the embryonic growth analysis and histopathological analysis. The tumor control outcomes were comparable between FLASH-RT and CONV-RT, confirming the iso-efficacy between the two strategies. These findings confirm the paradigm-shifting potential of FLASH-RT to enhance the therapeutic ratio, particularly in anatomically complex and radioresistant tumors such as pancreatic carcinoma, warranting further investigation in clinical settings. Additionally, a solid embryonic in vivo model has been introduced for comprehensive investigations on emerging radio-treatment approaches. While further investigations are necessary to optimize dose delivery and evaluate long-term outcomes, this research underscores the transformative promise of FLASH-RT in redefining radiotherapy standards for challenging malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAnimalsHumansChorioallantoic MembraneChick EmbryoCell Line, Tumor

Stichwörter der Autor:innen

FLASHalternative biomodelschorioallantoic membrane modelpancreatic carcinomaradiotherapy

Autor:innen und Institutionen

  • Center for Nanotechnology Innovation@NEST-Istituto Italiano di Tecnologia, Piazza San Silvestro 12, 56127 Pisa, Italy.
  • Radiation Oncology Unit, Pisa University Hospital "Azienda Ospedaliero-Universitaria Pisana", Via Roma 67, Pisa 56126, Italy.
  • Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy.
  • Centro Pisano Multidisciplinare Sulla Ricerca e Implementazione Clinica Della Flash Radiotherapy (CPFR), University of Pisa, Pisa 56126, Italy.
  • Center for Instrument Sharing of the University of Pisa (CISUP), University of Pisa, Pisa 56126, Italy.
  • Sordina IORT Technologies S.p.A., Research and development, Aprilia 04011, Italy.

ORCID-Profile: Valerio Voliani

Förderung

  • Ministero dell'Universit? e della Ricerca

Zitieren

APA

Giannini, N., Gonnelli, A., Gadducci, G., Puccini, P., Cavalieri, A., Masturzo, L., Pensavalle, J. H., Celentano, M., Di Martino, F., Di Cocco, F., Scatena, C., Naccarato, A. G., Menicagli, M., Sarogni, P., Frusca, V., Cioni, D., Aquaro, G. D., Voliani, V., & Paiar, F. (2025). FLASH Radiotherapy Enhances the Therapeutic Ratio in an Embryonic In Vivo Model of Pancreatic Carcinoma. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c19638

Vancouver

Giannini N, Gonnelli A, Gadducci G, Puccini P, Cavalieri A, Masturzo L, et al. FLASH Radiotherapy Enhances the Therapeutic Ratio in an Embryonic In Vivo Model of Pancreatic Carcinoma. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c19638

BibTeX
@article{Giannini2025,
  author = {Giannini, Noemi and Gonnelli, Alessandra and Gadducci, Giovanni and Puccini, Paola and Cavalieri, Andrea and Masturzo, Luigi and Pensavalle, Jake Harold and Celentano, Mariagrazia and Di Martino, Fabio and Di Cocco, Federico and Scatena, Cristian and Naccarato, Antonio Giuseppe and Menicagli, Michele and Sarogni, Patrizia and Frusca, Valentina and Cioni, Dania and Aquaro, Giovanni Donato and Voliani, Valerio and Paiar, Fabiola},
  title = {FLASH Radiotherapy Enhances the Therapeutic Ratio in an Embryonic In Vivo Model of Pancreatic Carcinoma},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c19638}
}
Kostenlos starten →